Recently, the Caspase 3 activity induced by EGCG treatments was also observed in bladder cancer cells SW780 [45] and chondrosarcoma cells [46], as well as in diabetic mice [47], indicating that EGCG plays a role in apoptosis via Caspase 3 activity. Here, CASP3 is linked to urinary bladder carcinoma.